Clinical trial Recruiting at 1 site Observational Ages 16 and up

Evaluating fracture classifications for distal radius fractures

Official title: Fracture Database of the University Hospital Basel: A REDCap Assisted Reliability and Validity Study of Fracture Classifications of the Distal Radius

Run by University Hospital, Basel, Switzerland · NCT05684042 · Data updated 2026-11-12

This study is trying to see if expert doctors classify distal radius fractures differently than what's recorded in a hospital database to help improve treatment and training for medical staff.

Quick facts

Study typeObservational
Ages16 Years and up
SexAll
Enrollment216 (estimated)
SponsorUniversity Hospital, Basel, Switzerland
Academic / other
Locations1 site (Basel)
StatusRecruiting
StartedJune 9, 2022
Main results expectedJune 2033
Study endsJune 2033
Registry record updatedDecember 9, 2024
Trial IDNCT05684042 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 16 and older who have undergone surgical treatment for a primary distal radius fracture.

Probably not a fit

Patients under 16 years old or those receiving conservative treatment for distal radius fractures will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project aims to assess the accuracy of classifications for distal radius fractures recorded in a fracture database at the University Hospital Basel. Since 2017, the database has collected data on patients treated surgically for extremity and pelvic fractures, focusing on quality assurance. The study will involve reclassifying selected fractures by a group of experts to compare their classifications with those in the database, identifying any significant discrepancies. This evaluation is crucial for improving clinical practices and training for medical staff.

Why it matters

Potential benefit: If successful, this study could enhance the accuracy of fracture classifications, leading to better patient outcomes and improved treatment protocols.

How similar studies have gone: While this approach focuses on quality assurance and classification accuracy, similar studies have shown that improving data quality can lead to better clinical outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients at least 16 years of age and regardless of gender
* Surgical treatment of a primary fracture of the distal radius was performed
* Pre-therapeutic radiographs of good quality and in two planes
* General consent for quality assurance and research was not rejected

Exclusion Criteria:

* Existence of a documented refusal
* Patients under the age of 16, as they are treated in the children's hospital
* Conservative treatment of the distal radius fracture
* Re-fracture after conservative or surgical treatment
* Incorrect planes and poor quality of X-rays
* Exclusive performance of a computed tomography, e.g. after polytrauma
* Duplicates within the database
* X-rays with forearm cast

Where it's running

  • University Hospital Basel, Orthopedics and Traumatology
    Basel, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Murat Bilici — University Hospital Basel, Clinic for Orthopedics and Traumatology
  • Study coordinator: Murat Bilici
  • Email: murat.bilici@usb.ch
  • Phone: +41 61 556 51 12

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.